Phase 1 Clinical Trials2020-04-09T14:53:23+00:00

Phase 1 Clinical Trials

Clinilabs Drug Development Corporation provides a full range of CNS Phase 1 capabilities, with extensive expertise and experience in all the early phase studies (below) required for regulatory approval.  We prioritize and support early stage development programs with access to 100 early-phase beds, enabling our customers to move their promising new chemical entities from proof-of-concept to pivotal trials faster.

  • First in human

  • First in class

  • Single ascending dose (SAD)

  • Multiple ascending dose (MAD)

  • Bioequivalence (BE)

  • Drug – drug interaction studies

  • Drug – alcohol interactions studies

  • Food effect studies

  • Pharmacokinetic (PK) studies

  • Pharmacodynamic (PD) studies

  • Kinetic-dynamic relationships

If you think compliance is expensive, try non-compliance.

– Former US Attorney General Paul McNulty